Tigefic Tigecycline Injection IP

Tigefic 50 mg Injection is a broad-spectrum antibiotic injection containing Tigecycline, used for the treatment of complicated bacterial infections caused by susceptible organisms. This Tigecycline 50 mg injection is especially effective against multidrug-resistant Gram-positive and Gram-negative bacteria, including MRSA, VRE, and ESBL-producing organisms.

Widely used in hospitals, ICUs, and critical care units, Tigefic Injection is prescribed for complicated skin and soft tissue infections, intra-abdominal infections, and hospital-acquired infections. It is administered via the intravenous (IV) route under strict medical supervision.